Scarica l'app Stockscreener
2.12
0.00%
0.00
Dopo l'orario di chiusura:
2.18
0.06
+2.83%
Precedente Chiudi:
$2.12
Aprire:
$2.11
Volume 24 ore:
402.52K
Relative Volume:
0.10
Capitalizzazione di mercato:
$26.11M
Reddito:
$130.00K
Utile/perdita netta:
$-19.22M
Rapporto P/E:
-1.119
EPS:
-1.8946
Flusso di cassa netto:
$-18.01M
1 W Prestazione:
-18.77%
1M Prestazione:
+19.77%
6M Prestazione:
-59.62%
1 anno Prestazione:
-60.67%
Intervallo 1D:
$1.9001
$2.16
Intervallo di 1 settimana:
$1.7501
$2.6499
Portata 52W:
$1.22
$7.92
Serina Therapeutics Inc Stock (SER) Company Profile
Nome
Serina Therapeutics Inc
Settore
Industria
Telefono
(256) 327-9630
Indirizzo
601 GENOME WAY, HUNTSVILLE
Compare SER vs VRTX, REGN, ARGX, ALNY, INSM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
SER
Serina Therapeutics Inc
|
2.12 | 26.11M | 130.00K | -19.22M | -18.01M | -1.8946 |
VRTX
Vertex Pharmaceuticals Inc
|
438.71 | 111.45B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
761.85 | 80.54B | 14.34B | 4.50B | 3.77B | 41.56 |
ARGX
Argen X Se Adr
|
746.42 | 46.32B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
318.85 | 42.29B | 3.71B | 313.75M | 465.38M | 2.2571 |
INSM
Insmed Inc
|
162.43 | 35.01B | 606.42M | -1.28B | -997.58M | -6.403 |
Serina Therapeutics Inc Stock (SER) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-14 | Iniziato | H.C. Wainwright | Buy |
Serina Therapeutics Inc Borsa (SER) Ultime notizie
Serina Therapeutics Announces NYSE American Acceptance of Continued Listing Compliance Plan - Sahm
Serina Therapeutics announces NYSE American acceptance of continued listing compliance plan - MarketScreener
Serina Therapeutics Announces NYSE American Acceptance Of Continued Listing Compliance Plan - TradingView
NYSE lets Serina stock keep trading as it works to regain compliance - Stock Titan
SER Technical Analysis & Stock Price Forecast - Intellectia AI
Serina Therapeutics (SER) stock surges over 39% after hours—here's why - MSN
Serina Therapeutics (SER) files 10-K amendment to correct auditor consent - stocktitan.net
SER Stock Price and Chart — AMEX:SER - TradingView
Serina Therapeutics POZ Drug Delivery Platform: Technology Overview, Pipeline, and Intellectual Property Portfolio - Minichart
Serina Therapeutics' 2025 net loss widens as R&D expenses jump - TradingView
Serina Therapeutics Reports Full Year 2025 Financial Results and Recent Business Highlights - marketscreener.com
Serina Therapeutics (NYSE: SER) posts 2025 loss while funding SER-252 trials - Stock Titan
[10-K] Serina Therapeutics, Inc. Fi... - Stock Titan
Serina Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - MarketScreener
Parkinson's drug candidate reaches patients as Serina lines up $30M - Stock Titan
Top Executive Makes Notable Move With Serina Therapeutics Stock - TipRanks
Serina Therapeutics CSO Moreadith sells $18,567 in stock - Investing.com
Serina Therapeutics CSO Moreadith sells $18,567 in stock By Investing.com - Investing.com Canada
Serina Therapeutics (SER) CSO exercises options then sells 6,500 shares - Stock Titan
Serina Therapeutics Raises Up to $30 Million to Advance SER-252 Parkinson’s Drug Trial and Secures Additional Funding Opportunities - Minichart
Serina Therapeutics to Present at 38th Annual Roth Conference - National Today
Serina Therapeutics to Present at the 38th Annual Roth Conference - Bitget
Serina Therapeutics Inc appoints Greg Bailey as co-chairman of boardSEC filing - MarketScreener
Serina Therapeutics IncAppoints Greg Bailey As Co-Chairman Of BoardSEC Filing - TradingView
Serina Therapeutics (SER) lines up $30M private placement plus $33.3M warrant upside - Stock Titan
Serina Therapeutics Inc. Faces Stock Volatility Amid Economic Challenges - StocksToTrade
Risk Check: What is the dividend yield of Serina Therapeutics IncEarnings Recap Summary & Daily Profit Focused Stock Screening - baoquankhu1.vn
Serina Therapeutics secures up to $30M in private placement - MSN
Serina Therapeutics Insider Sells $97,500 in Stock - National Today
Top Serina Therapeutics Executive Makes Notable Stock Move - TipRanks
Serina Therapeutics CSO sells $97,500 in shares By Investing.com - Investing.com Canada
Serina Therapeutics (SER) CSO exercises options and sells 39,000 shares - Stock Titan
Serina Therapeutics Inc. Rallies on Dynamic Market Expansion Prospects - timothysykes.com
Serina Therapeutics, Inc.: Fundamental Analysis and Financial Ratings | 2BO | US81751A1088 - marketscreener.com
Stock Market Today: Futures Drop Ahead Of 'Triple Witching' Session As Iran Threatens 'Zero Restraint'— FedEx, Super Micro In Focus (UPDATED) - Benzinga
Serina Therapeutics (SER) Stock Jumps 39% Following $63M Financing Deal and Leadership Announcement - MEXC
Serina Therapeutics (SER) Stock Climbs 39% on Private Placement and Greg Bailey Appointment - MEXC
Biotech Microcap Rockets After Securing Major Capital Infusion at Premium Valuation - The Globe and Mail
SER Stock Surges Amid Strategic Acquisitions and Partnerships - StocksToTrade
Serina Therapeutics (SER) Stock Soars 39% After Announcing $63M Funding and Leadership Boost - parameter.io
Serina Therapeutics (SER) Stock Soars 39% After $30M Funding Deal and Leadership Boost - MoneyCheck
Serina Therapeutics’ Stock Hits All-Time Low Amid Financial Challenges - timothysykes.com
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Serina Therapeutics (SER) Stock Surges Over 39% After Hours— Here's Why - Benzinga
Dow Falls Over 300 Points; US Initial Jobless Claims Fall - Sahm
Serina Therapeutics, Inc. Appoints Greg Bailey as Co-Chairman of the Board of Directors - marketscreener.com
Serina Therapeutics Raises $30 Million in Private Placement - marketscreener.com
Serina Therapeutics Secures up to $30 Million in Private - GlobeNewswire
Macro Review: What is the dividend yield of Serina Therapeutics IncTrade Entry Report & Smart Investment Allocation Insights - baoquankhu1.vn
12 Health Care Stocks Moving In Wednesday's After-Market Session - Benzinga
Serina Therapeutics, Inc. announced that it expects to receive $30 million in funding - marketscreener.com
Serina Therapeutics Inc Azioni (SER) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.49%
1.47%
Capitalizzazione:
|
Volume (24 ore):